These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26327695)

  • 1. Compromising the 19S proteasome complex protects cells from reduced flux through the proteasome.
    Tsvetkov P; Mendillo ML; Zhao J; Carette JE; Merrill PH; Cikes D; Varadarajan M; van Diemen FR; Penninger JM; Goldberg AL; Brummelkamp TR; Santagata S; Lindquist S
    Elife; 2015 Sep; 4():. PubMed ID: 26327695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An arsenite-inducible 19S regulatory particle-associated protein adapts proteasomes to proteotoxicity.
    Stanhill A; Haynes CM; Zhang Y; Min G; Steele MC; Kalinina J; Martinez E; Pickart CM; Kong XP; Ron D
    Mol Cell; 2006 Sep; 23(6):875-85. PubMed ID: 16973439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic addiction to high 26S proteasome level.
    Tsvetkov P; Adler J; Myers N; Biran A; Reuven N; Shaul Y
    Cell Death Dis; 2018 Jul; 9(7):773. PubMed ID: 29991718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells.
    Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
    J Cell Biochem; 2008 Jan; 103(1):270-83. PubMed ID: 17516511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the murine cardiac 26S proteasome complexes.
    Gomes AV; Zong C; Edmondson RD; Li X; Stefani E; Zhang J; Jones RC; Thyparambil S; Wang GW; Qiao X; Bardag-Gorce F; Ping P
    Circ Res; 2006 Aug; 99(4):362-71. PubMed ID: 16857966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and functions of the 20S and 26S proteasomes.
    Coux O; Tanaka K; Goldberg AL
    Annu Rev Biochem; 1996; 65():801-47. PubMed ID: 8811196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 20S proteasome as an assembly platform for the 19S regulatory complex.
    Hendil KB; Kriegenburg F; Tanaka K; Murata S; Lauridsen AM; Johnsen AH; Hartmann-Petersen R
    J Mol Biol; 2009 Nov; 394(2):320-8. PubMed ID: 19781552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The proteasome - structural aspects and inhibitors: a second life for a validated drug target].
    Reboud-Ravaux M
    Biol Aujourdhui; 2021; 215(1-2):1-23. PubMed ID: 34397372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECPAS/Ecm29-mediated 26S proteasome disassembly is an adaptive response to glucose starvation.
    Choi WH; Yun Y; Byun I; Kim S; Lee S; Sim J; Levi S; Park SH; Jun J; Kleifeld O; Kim KP; Han D; Chiba T; Seok C; Kwon YT; Glickman MH; Lee MJ
    Cell Rep; 2023 Jul; 42(7):112701. PubMed ID: 37384533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsm3/S5b participates in the assembly pathway of the 19S regulatory particle of the proteasome.
    Le Tallec B; Barrault MB; Guérois R; Carré T; Peyroche A
    Mol Cell; 2009 Feb; 33(3):389-99. PubMed ID: 19217412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Proteasome Activity Induces Formation of Alternative Proteasome Complexes.
    Welk V; Coux O; Kleene V; Abeza C; Trümbach D; Eickelberg O; Meiners S
    J Biol Chem; 2016 Jun; 291(25):13147-59. PubMed ID: 27129254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits.
    Acosta-Alvear D; Cho MY; Wild T; Buchholz TJ; Lerner AG; Simakova O; Hahn J; Korde N; Landgren O; Maric I; Choudhary C; Walter P; Weissman JS; Kampmann M
    Elife; 2015 Sep; 4():e08153. PubMed ID: 26327694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-Molecule Inhibitors of the Proteasome's Regulatory Particle.
    Muli CS; Tian W; Trader DJ
    Chembiochem; 2019 Jul; 20(14):1739-1753. PubMed ID: 30740849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of CYP2E1-dependent oxidant stress on activity of proteasomes in HepG2 cells.
    Kessova IG; Cederbaum AI
    J Pharmacol Exp Ther; 2005 Oct; 315(1):304-12. PubMed ID: 16002458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of the 19S proteasome complex increases yeast resistance to 4-NQO and oxidative stress via upregulation of Rpn4- and proteasome-dependent stress responsive genes.
    Karpov DS; Spasskaya DS; Nadolinskaia NI; Tutyaeva VV; Lysov YP; Karpov VL
    FEMS Yeast Res; 2019 Mar; 19(2):. PubMed ID: 30629175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docking of the proteasomal ATPases' carboxyl termini in the 20S proteasome's alpha ring opens the gate for substrate entry.
    Smith DM; Chang SC; Park S; Finley D; Cheng Y; Goldberg AL
    Mol Cell; 2007 Sep; 27(5):731-44. PubMed ID: 17803938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential roles of proteasome and immunoproteasome regulators Pa28αβ, Pa28γ and Pa200 in the degradation of oxidized proteins.
    Pickering AM; Davies KJ
    Arch Biochem Biophys; 2012 Jul; 523(2):181-90. PubMed ID: 22564544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co- and post-translational modifications of the 26S proteasome in yeast.
    Kikuchi J; Iwafune Y; Akiyama T; Okayama A; Nakamura H; Arakawa N; Kimura Y; Hirano H
    Proteomics; 2010 Aug; 10(15):2769-79. PubMed ID: 20486117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular model of the human 26S proteasome.
    da Fonseca PC; He J; Morris EP
    Mol Cell; 2012 Apr; 46(1):54-66. PubMed ID: 22500737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian 26S proteasomes remain intact during protein degradation.
    Kriegenburg F; Seeger M; Saeki Y; Tanaka K; Lauridsen AM; Hartmann-Petersen R; Hendil KB
    Cell; 2008 Oct; 135(2):355-65. PubMed ID: 18957208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.